Migraine, an extremely disabling neurological disorder, has a strong genetic component.
Since monogenic migraines (resulting from mutations or changes in a single gene) may help researchers
discover migraine pathophysiology, transgenic mice models harboring gene mutations
identified in Familial Hemiplegic Migraine (FHM) patients have been generated. Studies in these
FHM mutant mice models have shed light on the mechanisms of migraine and may aid in the identification
of novel targets for treatment. More specifically, the studies shed light on how gene mutations,
hormones, and other factors impact the pathophysiology of migraine. The models may also be
of relevance to researchers outside the field of migraine as some of their aspects are relevant to pain
in general. Additionally, because of the comorbidities associated with migraine, they share similarities
with the mutant mouse models of epilepsy, stroke, and perhaps depression. Here, we review the
experimental data obtained from these mutant mice and focus on how they can be used to investigate
the pathophysiology of migraine, including synaptic plasticity, neuroinflammation, metabolite
alterations, and molecular and behavioral mechanisms of pain.